Cargando…
Vaccine considerations for adult dermatology patients on immunosuppressive and immunomodulatory therapies: a clinical review
Adults with chronic inflammatory skin disease are at increased risk of vaccine-preventable illnesses and infections, likely because of the underlying disease itself and also their treatment with immunosuppressive and immunomodulatory medications. Despite the association between these agents and incr...
Autores principales: | Tan, Alice J, Streicher, Jenna L, Merola, Joseph F, Noe, Megan H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020387/ https://www.ncbi.nlm.nih.gov/pubmed/34755974 http://dx.doi.org/10.5070/D327955114 |
Ejemplares similares
-
Recommendations for COVID Vaccination for Dermatological Patients on Immunosuppressive/Immunomodulatory Therapy (IADVL Academy)
por: Munisamy, Malathi, et al.
Publicado: (2021) -
Immunosuppressive and immunomodulatory therapies in dermatology and coronavirus disease 2019 (COVID-19)
por: Mansouri, Parvin, et al.
Publicado: (2021) -
Impact of the COVID-19 Pandemic on Immunomodulatory and Immunosuppressive Therapies in Dermatology: Patient and Physician Attitudes in Argentina()
por: Zimman, S., et al.
Publicado: (2020) -
Immunosuppressive therapy in dermatology and PML
por: Sterry, Wolfram, et al.
Publicado: (2009) -
Monkeypox outbreak, vaccination, and treatment implications for the dermatologic patient: Review and interim guidance from the Medical Dermatology Society
por: Kumar, Anusha M., et al.
Publicado: (2023)